Stock Price Quote

MOREPEN LABORATORIES LTD.

NSE : MOREPENLABBSE : 500288ISIN CODE : INE083A01026Industry : Pharmaceuticals & DrugsHouse : Morepen
BSE61.501.33 (+2.21 %)
PREV CLOSE ( ) 60.17
OPEN PRICE ( ) 60.17
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 470198
TODAY'S LOW / HIGH ( )60.00 62.45
52 WK LOW / HIGH ( )41.66 100.8
NSE61.501.34 (+2.23 %)
PREV CLOSE( ) 60.16
OPEN PRICE ( ) 60.15
BID PRICE (QTY) 61.50 (2432)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4361421
TODAY'S LOW / HIGH( ) 59.96 62.37
52 WK LOW / HIGH ( )42 100.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
Sushil Suri - Chairman Sushil Suri - Managing Director
Registered Office

Address Morepen Village, Malkumajra,Nalagarh Road,Near Baddi,
Solan Dist,
Himachal Pradesh-173205

Phone 01795-246401 / 02 / 03 / 244590

Email plants@morepen.com

Website www.morepen.com

Registrars Details
MAS Services Ltd
T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi
Listing : BSE, NSE

NEWS

19Jun Morepen Laboratories incorporates whol
Morepen Laboratories has incorporated wholly owned subsidiary (WOS) by n..
23May Morepen Laboratories informs about out
Morepen Laboratories has that the Finance Committee of the Board of Dire..
13May Morepen Laboratories reports 29% fall
Morepen Laboratories has reported results for fourth quarter (Q4) and ye..
13May Morepen Laboratories informs about pr
Morepen Laboratories has informed that it enclosed a press release with..
13May Morepen Laboratories declines on repor
Morepen Laboratories is currently trading at Rs. 59.90, down by 0.48 poi..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit119.1100000000011015.76
Gross Profit 173.040000000001 1375.86
Operating Profit 333.0100000000011691.31
Net Sales 3819.3815545.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  31529.10 (1.67%)
M.Cap ( in Cr)66997.14
Sanofi Cons. Health (BSE)
peergroup  5075.20 (2.17%)
M.Cap ( in Cr)11688.50
JB Chem & Pharma (BSE)
peergroup  1771.25 (5.98%)
M.Cap ( in Cr)27657.06
Divi's Lab (BSE)
peergroup  6589.85 (1.49%)
M.Cap ( in Cr)174939.81
Wockhardt (BSE)
peergroup  1730.65 (2.58%)
M.Cap ( in Cr)28120.56

Shareholding Pattern

NON-INSTITUTION 60.72%
PROMOTERS 35.65%
FI/BANKS/INSURANCE 1.62%
GOVERNMENT 0.01%
MUTUAL FUNDS/UTI 0%
FII 0%

About Morepen Laboratories Ltd.

Morepen Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 61.5. Its current market capitalisation stands at Rs 3369.92 Cr. In the latest quarter, company has reported Gross Sales of Rs. 15375.94 Cr and Total Income of Rs.15501.59 Cr. The company's management includes Vipul Kumar Srivastava, Sharad Jain, Ranjit Khattar , Savita, Praveen Kumar Dutt, Sanjay Suri, Sushil Suri, Sushil Suri.

It is listed on the BSE with a BSE Code of 500288 , NSE with an NSE Symbol of MOREPENLAB and ISIN of INE083A01026. It's Registered office is at Morepen Village, Malkumajra,Nalagarh Road,Near BaddiSolan Dist-173205, Himachal Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are M Kamal Mahajan & Co, M Kamal Mahajan & Co LLP, Satinder Goyal & Co, SP Babuta & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.